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Abstract
Leber congenital amaurosis (LCA) is the most severe form of retinal dystrophy with an onset in the first year of life.
The most frequent genetic cause of LCA, accounting for up to 15% of all LCA cases in Europe and North-America, is
a mutation (c.2991+1655AG) in intron 26 of CEP290. This mutation generates a cryptic splice donor site resulting in
the insertion of an aberrant exon (exon X) containing a premature stop codon to CEP290 mRNA. In order to study
the pathophysiology of the intronic CEP290 mutation, we generated two humanized knock-in mouse models each
carrying ~6.3 kb of the human CEP290 gene, either with or without the intronic mutation. Transcriptional
characterization of these mouse models revealed an unexpected splice pattern of CEP290 mRNA, especially in the
retina. In both models, a new cryptic exon (coined exon Y) was identified in ~5 to 12% of all Cep290 transcripts. This
exon Y was expressed in all murine tissues analyzed but not detected in human retina or fibroblasts of LCA patients.
In addition, exon x that is characteristic of LCA in humans, was expressed at only very low levels in the retina of the
LCA mouse model. Western blot and immunohistochemical analyses did not reveal any differences between the two
transgenic models and wild-type mice. Together, our results show clear differences in the recognition of splice sites
between mice and humans, and emphasize that care is warranted when generating animal models for human genetic
diseases caused by splice mutations.
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Introduction
Leber congenital amaurosis (LCA; OMIM 204000) is a group
of rare and severe inherited retinal dystrophies with a
prevalence of ~1:50,000 individuals worldwide [1,2]. The
clinical characteristics of LCA include severe and early vision
loss that appears in the first year of life, amaurotic pupils,
sensory nystagmus and the absence of electrical signals on
electroretinogram (ERG) [3]. Like other retinal disorders such
as retinitis pigmentosa (RP; OMIM 268000), LCA shows a high
genetic heterogeneity. Currently, mutations in 19 different
genes have been identified (RetNet: https://sph.uth.edu/retnet),
mainly segregating in an autosomal recessive manner. The
most frequently mutated LCA gene is CEP290 that encodes
the centrosomal protein 290 kDa [3,4]. The most prevalent
LCA-causing mutation in CEP290, accounting for up to 15% of
LCA cases in many Western countries, is a deep-intronic
change (c.2991+1655AG; p.C998*) that generates a strong
splice donor site which results in the insertion of a cryptic exon
with a premature stop codon into ~50% of CEP290 transcripts
[4-6].
To date, more than one hundred mutations have been
identified in CEP290 [4] (CEP290 homepage - Eye diseases –
LOVD: http://grenada.lumc.nl/LOVD2/eye/home.php?
select_db=CEP290), causing a wide spectrum of phenotypes
ranging from isolated retinal dystrophy (LCA, early-onset RP)
[5,7] to more severe syndromes such as Senior-Løken
syndrome (SLS; OMIM 266900) [8], Joubert syndrome (JS;
OMIM 213300) [9], Bardet-Biedl syndrome (BBS; OMIM
209900) [10] and Meckel-Grüber syndrome (MKS; OMIM
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249000) [11]. Unfortunately, no clear phenotype-genotype
correlation has been established yet. The prevalent intronic
change, however, is predominantly found in individuals with
non-syndromic retinal dystrophy and is considered to be a
hypomorphic mutation.
The CEP290 gene was first isolated from human brain cDNA
libraries, and encompasses 54 exons that encode a 2479
amino acid protein [12]. CEP290 has been localized to the
centrosome and to the transition zone of cilia [13,14]. The
exact physiological role of CEP290 remains unclear, although it
has been shown that it plays an important role in the regulation
of ciliary protein trafficking and cilium assembly [13,15]. In
photoreceptor cells, CEP290 localizes to the connecting cilium
[16], similar to approximately one third of proteins encoded by
retinal dystrophy genes [17]. The connecting cilium is the
transition zone of the photoreceptor sensory cilium, connecting
the inner and the outer segment of rods and cones, the light-
sensitive neurons responsible of the conversion of light stimuli
into chemical signals that are transmitted to the brain [18].
Two naturally occurring mutant Cep290 animal models have
been described to date. The murine rd16 model carries a
genomic deletion encompassing exons 35-39 of Cep290, that
results in an in-frame deletion of 897 bp in Cep290 mRNA.
These mice show an early, fast and progressive photoreceptor
degeneration, where only one row of photoreceptor cell nuclei
is detected at postnatal day 30 (P30) [16]. In a subpopulation of
Abyssinian cats with retinal degeneration, an intronic mutation
(c.6960+9TG) has been identified. This mutation generates a
new strong canonical splice donor site that inserts four
nucleotides into CEP290 mRNA, causing a frameshift that
results in a premature stop codon after two amino acids [19].
The first clinical symptoms appear at the age of seven months
when reduced electroretinogram recordings are detected as a
result of rod degeneration that is followed by cone death,
leading to complete blindness at the age of 3-5 years [20].
In order to study and understand the pathophysiology of the
intronic CEP290 mutation c.2991+1655AG, we have generated
two humanized mouse models, in which human exon 26, intron
26 (with or without the LCA mutation) and exon 27 were
inserted into the murine Cep290 gene via homologous
recombination. A detailed characterization of these mice at the
transcriptional level revealed unexpected splicing of CEP290
mRNA, that was only partially in line with the aberrant splicing
observed in patients with CEP290-associated LCA. Our data
suggest species-specific differences in the splicing machinery
between mice and humans, indicating that mice may not
always represent suitable models to study the pathogenic
mechanisms underlying genetic variants that affect splicing.
Materials and Methods
Ethics statement
All procedures were performed after obtaining approval from
the Radboud University Nijmegen ethics committee for
experimental animal research (RU-DEC-2012-023), and
according to the regulations of the ARVO statement for the use
of animals in ophthalmic and vision research. For human skin
biopsies written informed consent was gathered from all
individuals in Clinical Genetics Center Nijmegen by signing the
declaration of permission for the use of body material
(Toestemmingsverklaring gebruik lichaamsmateriaal) of the
Radboud University Medical Center and our research followed
the tenets of the Declaration of Helsinki. All procedures were
carried out in The Netherlands.
Generation of the transgenic models
Two animal models were generated by GenOway (Lyon,
France). Briefly, the targeting vector contained the human
genomic region between introns 25 and 27, either without
(Cep290hum/hum) or with the c.2991+1655AG mutation
(Cep290lca/lca). Neomycine (NEO) and Diphtheria Toxin A (DTA)
cassettes were also subcloned for positive and negative
selection, respectively. The final vector was electroporated in
129Sv/Pas ES cells. A total of 260 clones were positively
selected. After validating the homologous recombination event
at the 5’- and the 3’-end by PCR and southern blotting, four ES
cell clones for Cep290hum/hum and one for Cep290lca/lca were
isolated. These clones were injected in blastocysts from
C57BL/6J females and injected in pseudo-pregnant females of
the same strain. Based on the colour, four highly chimeric
males were selected for breeding with Cre deleter females in
order to excise the NEO cassette for each model. Excision was
validated by PCR and Southern blot. The resulting
heterozygous animals were used to obtain homozygous
offspring. Wild-type C57BL/6J mice (Cep290wt/wt) were used as
a reference in all analyses.
Animal handling, tissue dissection and preparation of
the samples
Tissue samples were obtained from postnatal day 150
(P150) Cep290wt/wt, Cep290hum/hum and Cep290lca/lca models.
Animals were euthanized with CO2 followed by cervical
dislocation. Retina, brain, kidney, liver, spleen, testis and lung
were dissected and immediately frozen in liquid nitrogen for
RNA and protein isolation, whereas for cryosectioning, eyes
were enucleated, embedded in OCT (Optical Cutting
Temperature compound, Tissue-Tek, Sakura Finetek,
Torrance, CA) and frozen in isopentane and liquid nitrogen.
From each of the three models, two animals were used for
RNA isolation, two for immunohystochemistry and four for
protein analysis.
Cell culture of human fibroblast cell lines
Fibroblast cell lines derived from skin biopsies of individuals
with CEP290-associated LCA or healthy controls, were
cultured in DMEM, supplemented with 20% fetal bovine serum,
1% penicillin-streptomycin and 1% of sodium pyruvate at 37°C
and 5% CO2. Informed consent was gathered from all
individuals and our research followed the tenets of the
Declaration of Helsinki.
RNA isolation
Several tissues from P150 Cep290wt/wt, Cep290hum/hum and
Cep290lca/lca mice were obtained for transcriptional analysis.
Twenty milligrams of tissue (brain, kidney, liver, spleen, testis
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and lung) and a pool of two retinas from different animals of the
three different mouse models were used for RNA isolation
(Nucleospin RNA II, Düren, Germany). For fibroblast cell lines,
RNA was isolated from ~1.5 million cells by using the same kit
following the manufacturer’s protocol. Human adult retina RNA
was purchased from Clontech (Mountain View, CA).
RT-PCR and transcriptional analysis
One microgram of RNA (from tissue, fibroblasts or human
retina) was used for cDNA synthesis by using the iScript cDNA
Synthesis kit (Bio-Rad, Hercules, CA) at a final volume of 20 µl
and then diluted by adding 50 µl of RNAse-free H2O. For tissue
expression analysis, all reaction mixtures (25 µl) contained 10
µM of each primer pair, 2 µM of dNTPs, 1.5 mM MgCl2, 10% Q-
solution (Qiagen, Venlo, Netherlands), 1 U of Taq polymerase
(Roche, Penzberg, Germany) and 5 µl of diluted cDNA. PCR
conditions were 94°C for 2 min, followed by 35 cycles of 20 s at
94°C, 30 s at 58°C and 30 s at 72°C, with a final extension step
of 2 min at 72°C. Amplicons were analyzed by agarose
electrophoresis. Semi-quantification was performed using
Image J software [21]. Actin expression was used to compare
and normalize the samples, primers for actin amplification were
designed to amplify both the human and the mouse gene.
Oligonucleotide sequences are listed in Table S1.
Western blot analysis
A pool of two retinas of different animals from each mouse
model were homogenized in 200 µl of RIPA buffer (50 mM Tris
pH 7.5, 1 mM EDTA, 150 mM NaCl, 0.5% Na-Deoxycholate,
1% NP40 plus protease inhibitors). Protein quantification was
performed with a BCA kit (Thermo Fisher Scientific, Waltham,
MA). For CEP290 detection, ~170 µg of total protein lysate
supplemented with sample buffer was loaded onto a NuPage
3-8% tris-acetate gel (Life technologies, Carlsbad, CA). The
electrophoresis was carried out for 4 h at 150 V. For
normalization with an anti-α-tubulin antibody, ~30 µg of the
same protein lysates were loaded onto a NuPage 4-12% bis-
acrylamide tris-glycine gel (Life technologies, Carlsbad, CA)
and run for 2 h at 150 V. A protein lysate from HEK293-T cells
overexpressing FLAG-tagged CEP290 was used as a positive
control (40 µg and 10 µg were loaded for CEP290 and tubulin
detection, respectively). All lysates were boiled for 5 min at
98°C prior to loading. Proteins were transferred to a PVDF
membrane (GE Healthcare, Little Chalfont, UK) overnight at 25
V at 4°C. Blots were blocked in 5% non-fat milk in PBS,
incubated overnight at 4°C with rabbit anti-CEP290 (dilution
1:750, Novus Biological, Littleton, CO) or mouse anti-α-tubulin
(dilution 1:2000, Abcam, Cambridge, UK) in 0.5% non-fat milk
in PBS, washed in PBST (4 x 5 min), incubated with the
appropriate secondary antibodies for 1 h at room temperature
(RT), washed in PBST (4 x 5 min) and developed using the
Odissey Imaging System (Li-Cor Biosciences, Lincoln, NE).
Western blot analysis was performed in duplo. Semi-
quantification was performed using Image J software [21].
Immunohistochemistry
Seven micrometer cryosections were dried for 1 h at RT,
washed in PBS to remove the OCT, permeabilized for 20 min
in 0.01% Tween in PBS and blocked for 30 min (0.1%
ovalbumin and 0.5% fish gelatine in PBS). Primary antibody
incubation was performed overnight at 4°C by diluting the
antibodies in blocking solution. The next day, sections were
washed in PBS (3 x 10 min), incubated for 45 min at RT with
the corresponding Alexa fluor-conjugated secondary antibodies
and DAPI, washed in PBS (3 x 10 min) and mounted using
Prolong Gold antifade kit (Life Technologies, Carlsbad, CA).
The antibodies and dilutions used were: 1:300 for rabbit anti-
CEP290 (Novus Biological, Littleton, CO), 1:1000 for mouse
anti-acetylated tubulin (Sigma-Aldrich, St. Louis, MO) and
1:500 for secondary antibodies Alexa Fluor 488 and 568 raised
in goat against rabbit and mouse IgGs, respectively (Molecular
Probes, Eugene, OR).
Results
Generation of the humanized models
The murine Cep290 gene contains 53 exons (one less than
in humans) and shares a high homology at DNA (86%) and
protein (87% homology and 94% similarity) levels with human
CEP290 (Figure 1A). In order to generate a humanized knock-
in mouse model that would mimic the genotype and phenotype
associated with the deep-intronic LCA-causing mutation, a
recombination strategy was designed that consisted of the
replacement of mouse exons 25 (mE25) and 26 (mE26), as
well as intron 25 (mI25), by the human counterparts (hE26,
hI26/hI26mut and hE27) (Figure 1B). All recombination events
were validated by PCR and Southern blot analysis (data not
shown). The isolated positive ES-cell clones were injected in
blastocysts that were implanted in pseudo-pregnant females.
Highly chimeric males were bred with Cre deleter females to
excise the NEO cassette. The resulting heterozygous mice
were used to obtain homozygous animals, which were viable
and fertile. Subsequent breedings were done between
homozygous animals.
Transcriptional analysis of Cep290 in the humanized
models
To determine whether the humanization of the murine
Cep290 would compromise the general Cep290 gene
expression, we determined by RT-PCR the transcriptional
levels of Cep290 in two different regions of Cep290 cDNA,
using actin expression as a reference (Figure 2). First, we
amplified the region from exon 10 to exon 13 (Figure 2A),
which is not affected by the recombination. In addition, we
performed a PCR from mouse exons 24 to 27, which
encompasses the humanized region (hE26-hE27) instead of
mE25 and mE26 (Figure 2B). In both cases, no differences in
the amount of Cep290 transcripts were observed between the
two models (Cep290lca/lca and Cep290hum/hum) and the wild-type
mice (Cep290wt/wt), indicating that the human exons did not alter
the expression levels of Cep290 in mouse. Intriguingly
however, especially in the retina, additional bands were
detected in both the Cep290hum/hum and the Cep290lca/lca model
but not in wild-type mice. In lymphoblastoid cell lines derived
from LCA patients homozygously carrying the intronic CEP290
mutation, two different CEP290 transcripts are detected in
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equal ratios, the correctly spliced product and an aberrant one,
that contains the 128-bp cryptic exon X that introduces a
premature stop codon [22]. In the Cep290lca/lca model, some
minor bands were detected, that could represent transcripts
which include the 128-bp-exon X. However, additional bands
were also observed in the Cep290hum/hum mice (Figure 2B),
suggesting new unexpected splice variants caused by the
humanization of the murine Cep290 locus.
To investigate these aberrant splicing events in more detail,
we used primers that were located in the human exons (hE26
and hE27). Due to the high homology of these two exons
between both species (E26: 93% and E27: 87%), we designed
the primers in the regions with the lowest sequence homology
to ensure amplification of only the human exon. As expected,
the two humanized models, but not the wild-type mice, showed
robust amplification of the human exons. However, also in wild-
type mice, some products were detected in the tissues where
Cep290 is most highly expressed, such as retina, kidney or
testis, likely due to the high similarity between the human and
mouse CEP290 exons (Figure 2C). In line with the results
found using primers in mE24 and mE27, again, aberrant splice
products were detected in the retinas of both humanized
mouse models (Figure 2C).
Expression of CEP290 cryptic exons in humans and
mice
The fact that the Cep290hum/hum model also showed evidence
of aberrant Cep290 splicing, whereas only one transcript was
expected (Figure 3A), prompted us to study the nature of these
aberrant splice products in depth. Sanger sequencing analysis
revealed the presence of a new exon of 116 bp (coined exon
Y), which was found to be also located in human intron 26,
downstream of exon X (starting position exon Y: c.2992-1603).
RT-PCR analysis using a primer located in exon Y allowed us
to observe that Cep290 transcripts encoding exon Y were
expressed in almost all tissues, but most prominent in the
retina (Figure 3B), both in the Cep290hum/hum and in the
Cep290lca/lca model. When using a primer located in exon X, two
bands were observed derived from the retina of Cep290lca/lca
mice (Figure 3C). Sequence analysis revealed that the most
prominent band corresponded to a Cep290 transcript
containing both exons X and Y. Cep290 transcripts that
contained only exon X were also found, but expressed at very
low levels that were hardly detectable. In total, we were able to
identify one transcript in the Cep290wt/wt animals, two in the
Cep290hum/hum and four in the Cep290lca/lca model (Figure 3D).
Semi-quantification of all aberrant splicing events revealed that
in the Cep290hum/hum model, approximately 5% of Cep290
Figure 1.  Generation of the Cep290 humanized mouse models.  (A) Structure of the CEP290 gene in human and mouse (drawn
to scale). (B) Two mouse models were generated by introducing human exons 26 and 27 and intron 26, either with or without the
LCA-causing mutation (depicted with *), to the mouse Cep290 gene. Human and mouse loci, targeting vector and recombinant
locus are depicted. Arrows and letters indicate the position of the oligonucleotides (see Table S1).
doi: 10.1371/journal.pone.0079369.g001
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 transcripts contained exon Y, whereas in the Cep290lca/lca
model, ~14% of all Cep290 transcripts contained aberrant
exons, i.e. exon Y, exon X or both (Figure 3D). Following the
identification of these unexpected splicing events, we
investigated whether exon Y is a naturally occurring exon in
human tissues. For that purpose, RNA from human retina as
well as from fibroblast cells from healthy and LCA
(homozygously carrying the CEP290 intronic mutation)
individuals were used, together with retinal RNA from the
Cep290wt/wt and Cep290lca/lca mice. RT-PCR analysis revealed
that transcripts containing exon Y were not detected in healthy
retinas nor in fibroblasts derived from individuals with CEP290-
associated LCA (Figure 4). Moreover, we observed again that
the transcripts containing exon X are less abundant than those
containing exon Y in Cep290lca/lca retinas (Figure 4).
Western blot and immunohistochemical analysis of
mouse retinas
The insertion of exon X, exon Y, or both, to the regular
Cep290 transcript, in all cases is predicted to cause a frame-
shift and premature termination of the Cep290 protein. To
determine the effect of these various splicing events on the
amount of CEP290 protein levels, Western blot analysis was
performed using retinal protein lysates from our mouse models.
Large amounts (>150 µg) of total protein were required to
robustly detect CEP290. Western blot analysis revealed no
significant differences among the three models (Figure 5),
indicating that the inclusion of any or both cryptic exons to only
a small percentage of Cep290 transcripts does not significantly
alter Cep290 protein levels.
Finally, retinal sections from Cep290wt/wt, Cep290hum/hum and
Cep290lca/lca mice at P150 were analyzed by
immunohistochemistry. The overall morphology of all retinas
was similar, as were the amounts of photoreceptor cell nuclei in
the different models. In addition, CEP290 was correctly
localized at the connecting cilium of photoreceptors in all three
models (Figure 6), illustrating that the low abundance of
aberrant Cep290 splicing also does not appear to affect the
structural integrity of the retina.
Discussion
Rodents, in particular mice, have been widely used in the
last decades to shed light on the pathophysiology of several
diseases as well as for the development of therapeutic trials. In
the field of vision science, they are particularly useful because
of their relatively short lifespan, which allows a quick read-out
of the progression of retinal degeneration. In addition, there are
several naturally occurring retinal degeneration models [23,24],
the interactions between retinal cells are similar in humans and
mice [25], and more importantly, the genetic manipulation and
subsequent phenotypic characterization are very well
established.
Figure 2.  Transcriptional characterisation of Cep290 in humanized mouse models.  (A-B) Cep290 expression levels in various
mouse tissues were assessed by RT-PCR. Regions containing murine exons 10 to 13 (A) and 24 to 27 (B) were analyzed. No
differences were observed. (C) Amplification using human primers was also assessed in the three models. Only humanized models
showed amplification. (D) Actin was used for normalization and comparison among tissues and models. MQ: H2O (negative control);
B: Brain; K: Kidney; R: Retina; Lu: Lung; S: Spleen; T: Testis and Li: Liver.
doi: 10.1371/journal.pone.0079369.g002
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Here, we generated a transgenic CEP290 knock-in model by
introducing the deep intronic mutation that causes LCA in
humans [5] and its flanking exons to elucidate the mechanisms
that cause photoreceptor cell death in these patients. In
addition, mimicking the splice abnormalities that are observed
in LCA patients in a mice model would allow to determine the
efficacy of therapeutic interventions, like for instance antisense
oligonucleotide-based rescue of aberrant CEP290 splicing that
was shown to be effective in patient cell lines by us and others
[22,26]. The high homology between human and mouse exons
allowed the generation of the animal model without changing
the open reading frame of Cep290 and only slightly altering the
Figure 3.  Analysis of the CEP290 cryptic exons.  (A) Expected transcripts for each model. (B) Exon Y is expressed in all tissues
in either Cep290hum/hum and Cep290lca/lca mice. (C) Only in the Cep290lca/lca model, exon X is expressed, either with exon Y or without,
at very low levels. The arrow indicates the band that contains both cryptic exons (exon X and exon Y) in the same transcript.
Cep290lca/lca PCR products were run longer to clearly separate the two different bands. (D) Schematic representation of the different
transcripts containing cryptic exons found in the three mouse models. Mouse exons and introns are depicted in black, while human
exons and introns are represented in blue. Cryptic exons X and Y are shown in grey and red, respectively. Arrows and letters
indicate the position of the oligonucleotides in the cryptic exons. Semi-quantification was performed using ImageJ software [21].
MQ: H2O (negative control); F: human LCA fibroblasts; B: Brain; K: Kidney; R: Retina; Lu: Lung; S: Spleen; T: Testis and Li: Liver.
doi: 10.1371/journal.pone.0079369.g003
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amino acid composition of CEP290. In addition, the naturally
occurring Cep290 mouse model (rd16) shows a clear early-
onset retinal phenotype, indicating an essential role for this
gene in the mouse retina [16]. As expected, the expression
levels of the Cep290 gene were not altered in our humanized
Figure 4.  Analysis of the cryptic exons X and Y in human
retina and fibroblast cell lines.  The expression of the
CEP290 human exons 26 and 27, and the cryptic exons Y and
exon X were assessed in tissues derived from both mice and
humans. Actin was used for normalization.
doi: 10.1371/journal.pone.0079369.g004
Figure 5.  CEP290 protein analysis in Cep290 mouse
models.  Representative CEP290 immunodetection in P150
retinas from the three different mouse models. A CEP290-Flag
construct was expressed in HEK293-T cells and used as a
positive control. Tubulin was used for normalization.
doi: 10.1371/journal.pone.0079369.g005
mouse models, with highest expression shown in retina and
testis. However, when the composition of Cep290 transcripts
was analyzed in detail, we did not detect the same ratio of
correctly and aberrantly spliced transcripts (approximately 1:1)
as detected in cell lines of LCA patients carrying the intronic
CEP290 mutation [22]. Instead, unexpected aberrant splicing
events were detected, that included the recognition of a novel
exon Y, in addition to exon X. In total, in the Cep290lca/lca model,
four different transcripts were observed, including two that
contained the aberrant exon X associated with LCA (Figure
3D). Nevertheless, the amount of all aberrantly spliced
transcripts collectively was less than 15% of the total Cep290
expression, which is most probably not enough to compromise
retinal function. This is further supported by the absence of
significant differences in CEP290 protein levels between the
models assessed by Western blot analysis, and of any
abnormalities in retinal structure following
(immuno)histochemical analysis of retinal sections.
In the past, others have successfully used humanized knock-
in mouse models to mimic the pathophysiological mechanisms
underlying splice site mutations for several inherited diseases
[27-30]. In this study, even though the humanization of mouse
Cep290 was not compromising the gene expression in general,
the splicing machinery of the mouse appeared not to be able to
recognize the human splice acceptor site or the splice donor
site that is generated by the intronic CEP290 mutation,
suggesting differential recognition of splice sites in humans vs.
mice. In addition, the substitution of the murine intron by the
human one generated another cryptic exon, robustly expressed
in the mouse retina, but not found in human retinas nor in
fibroblasts. Again, these results point to differences in the
splicing machineries in mice vs. humans, as it has already
been suggested for other retinal dystrophy genes [31]. One
example is CERKL, which shows a high transcriptional
complexity in human and mouse retina, showing different
alternative splice events between species in addition to the use
of alternative promoters [31]. In addition, it has been showed
that the recognition of splice sites are species-, regulator
region- and RNA-structure-dependent [32], suggesting that the
human exon X might have an inaccessible structure for the
murine spliceosome or that some enhancers favor the insertion
of exon Y in mice.
In the last decade, the use of other non-murine animal
models has been regularly preferred to study retinal
dystrophies, for a number of reasons. It is well known that like
in humans, primate and raptor retinas contain a cone-enriched
zone called fovea, whereas in mice the cones are
homogeneously distributed throughout the retina [18], thus less
reminiscent of the human situation. In addition, several genes
in which mutations are causative for retinal dystrophy in
humans do not have an orthologue in rodent species, like for
instance EYS [33,34]. Other mutant mouse models do not
show any phenotype, potentially because of functional
redundancy. For example, the GCAP1 (GUCA1A) and GCAP2
(GUCA1B) proteins are guanylate cyclases activators involved
in phototransduction. Although in humans, mutations in either
of these genes can cause retinal dystrophy, mice only show a
phenotype when both genes are knocked out at the same time
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[35,36]. Occasionally, the protein might not be localized in the
expected cell type, as is the case with the aforementioned
CERKL gene, which in mouse is mainly expressed in ganglion
cells rather than in photoreceptors [37]. Other genes that, when
mutated in mice, do not resemble the human phenotypes are
USH2A and RDH12. In Ush2a-/- mice retinal degeneration only
appears at very late stages [38], whereas in Rdh12 knock-out
mice, no retinal phenotype is observed at all [39]. Taken
together, these examples suggest that proteins involved in
visual function might not play the same roles or are not
involved in the same critical functions in humans vs. mice. The
question that now arises is which is the best model to study
retinal dystrophies. Although there are models with
anatomically more similar eyes (i.e. dogs or primates), in these
medium- and large-sized animal models, genetic manipulation
is practically impossible due to experimental, financial and
ethical restrictions. In the past, other naturally occurring animal
models have enabled the study of the retinal degeneration and
the start of the development of new therapies, such as RPE65
gene augmentation therapy in dogs [40]. However, compared
to mice, the disease is only manifested after several years and
also the progression is slower.
In summary, we have generated and characterized a
humanized transgenic mouse model that carries the prevalent
intronic Cep290 mutation causative for LCA. Despite the
recognition of expected and unexpected cryptic exons, the total
amount of aberrantly spliced Cep290 transcripts was less than
15%, and thereby does not mimic the aberrant CEP290
splicing observed in individuals with CEP290-associated LCA.
Our results indicate that the mouse may not be a suitable
model to study the pathophysiology of the intronic CEP290 c.
2991+1655AG mutation, due to differential recognition of splice
sites between humans and mice. Together, our results
emphasize that caution is warranted when generating animal
Figure 6.  Morphological and CEP290 immunolocalization analyses in P150 mouse retinas.  Immunodetection of CEP290 and
acetylated tubulin in retinal sections from Cep290wt/wt, Cep290hum/hum and Cep290lca/lca mice, at P150. Images were taken at 200X (A)
and 400x (B) magnifications. CEP290 (green) is located in the connecting cilium (CC) and remains unaltered in the humanized
models. Nuclei were marked with DAPI (blue) and CC with acetylated tubulin (red). GCL: ganglion cell layer; IPL: inner plexiform
layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer; PhL: photoreceptor layer; RPE: retinal pigment
epithelium; IS: inner segment; CC: connecting cilium; OS: outer segment.
doi: 10.1371/journal.pone.0079369.g006
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models for human genetic diseases caused by splice
mutations.
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